Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance
The repeated waves of the novel coronavirus disease (COVID-19) across the world have resulted in major issues in different facets of life, especially in healthcare. In low- and middle-income countries (LMICs) such as India, the effects of the pandemic have been devastating, driving communities, hosp...
| Autores principales: | , |
|---|---|
| Formato: | Journal Article |
| Lenguaje: | Inglés |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://hdl.handle.net/10568/117313 |
| _version_ | 1855529469065822208 |
|---|---|
| author | Jampani, Mahesh Chandy, S. J. |
| author_browse | Chandy, S. J. Jampani, Mahesh |
| author_facet | Jampani, Mahesh Chandy, S. J. |
| author_sort | Jampani, Mahesh |
| collection | Repository of Agricultural Research Outputs (CGSpace) |
| description | The repeated waves of the novel coronavirus disease (COVID-19) across the world have resulted in major issues in different facets of life, especially in healthcare. In low- and middle-income countries (LMICs) such as India, the effects of the pandemic have been devastating, driving communities, hospitals, and government into a crisis mode. There were a series of lockdowns and other pandemic-related restrictions since March 2020, which appeared to have curbed the infection rates in the first wave. However, since April 2021, the number of people infected and deaths associated with the second wave of COVID-19, specifically due to the delta variant, has been alarming. As a consequence, governments and scientific communities have been keen on finding an effective treatment for COVID-19. |
| format | Journal Article |
| id | CGSpace117313 |
| institution | CGIAR Consortium |
| language | Inglés |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Wiley |
| publisherStr | Wiley |
| record_format | dspace |
| spelling | CGSpace1173132024-10-03T07:40:54Z Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance Jampani, Mahesh Chandy, S. J. covid-19 antimicrobial resistance risk The repeated waves of the novel coronavirus disease (COVID-19) across the world have resulted in major issues in different facets of life, especially in healthcare. In low- and middle-income countries (LMICs) such as India, the effects of the pandemic have been devastating, driving communities, hospitals, and government into a crisis mode. There were a series of lockdowns and other pandemic-related restrictions since March 2020, which appeared to have curbed the infection rates in the first wave. However, since April 2021, the number of people infected and deaths associated with the second wave of COVID-19, specifically due to the delta variant, has been alarming. As a consequence, governments and scientific communities have been keen on finding an effective treatment for COVID-19. 2021-12 2021-12-31T21:57:53Z 2021-12-31T21:57:53Z Journal Article https://hdl.handle.net/10568/117313 en Open Access Wiley Jampani, Mahesh; Chandy, S. J. 2021. Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance. Health Science Reports, 4(4):e459. [doi: https://doi.org/10.1002/hsr2.459] |
| spellingShingle | covid-19 antimicrobial resistance risk Jampani, Mahesh Chandy, S. J. Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance |
| title | Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance |
| title_full | Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance |
| title_fullStr | Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance |
| title_full_unstemmed | Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance |
| title_short | Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance |
| title_sort | increased antimicrobial use during covid 19 the risk of advancing the threat of antimicrobial resistance |
| topic | covid-19 antimicrobial resistance risk |
| url | https://hdl.handle.net/10568/117313 |
| work_keys_str_mv | AT jampanimahesh increasedantimicrobialuseduringcovid19theriskofadvancingthethreatofantimicrobialresistance AT chandysj increasedantimicrobialuseduringcovid19theriskofadvancingthethreatofantimicrobialresistance |